We are live on ! Find out more
IMCR icon

Immunocore

125 hedge funds and large institutions have $1.92B invested in Immunocore in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 51 increasing their positions, 37 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

8,356% more call options, than puts

Call options by funds: $12.8M | Put options by funds: $151K

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

38% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 37

4% more funds holding

Funds holding: 120125 (+5)

3.38% more ownership

Funds ownership: 73.44%76.82% (+3.4%)

9% less capital invested

Capital invested by funds: $2.12B → $1.92B (-$198M)

13% less funds holding in top 10

Funds holding in top 10: 87 (-1)

Holders
125
Holders Change
+5
Holders Change %
+4.17%
% of All Funds
1.98%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
14
Increased
51
Reduced
37
Closed
8
Calls
$12.8M
Puts
$151K
Net Calls
+$12.6M
Net Calls Change
-$11M
Name Holding Trade Value Shares
Change
Change in
Stake
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
126
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$2.71M -45,200 Closed
SCM
127
Soleus Capital Management
Connecticut
-$983K -16,400 Closed
Brown Advisory
128
Brown Advisory
Maryland
-$240K -4,000 Closed
PCM
129
Prelude Capital Management
New York
-$239K -3,985 Closed
OC
130
Oppenheimer & Co
New York
-$208K -3,476 Closed
Deutsche Bank
131
Deutsche Bank
Germany
-$31.3K -522 Closed
TAM
132
Tucker Asset Management
Colorado
-$480 -8 Closed

IMCR Hedge Fund Activity: Q3 2023 in Review

125 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Immunocore (IMCR) for Q3 2023, worth a combined $1.92B — down 9.4% from $2.12B a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new IMCR positions and 8 closed out — a net gain of 6 holders — while 51 added to existing stakes and 37 trimmed.

The largest buyer was Nicholas Investment Partners, adding an estimated $30.1M. The largest seller was Holocene Advisors, cutting an estimated $31.3M.

  • 125 institutional investors held Immunocore (IMCR) as of Q3 2023, up from 120 in Q2 2023.
  • Funds reported $1.92B of Immunocore stock for Q3 2023, down 9.4% quarter-over-quarter.
  • 14 funds opened new Immunocore positions in Q3 2023 and 8 closed out, a net change of +6 holders.
  • The largest Immunocore buyer in Q3 2023 was Nicholas Investment Partners, an estimated $30.1M added.
  • The largest Immunocore seller in Q3 2023 was Holocene Advisors, an estimated $31.3M sold.

Based on aggregated 13F filings for Q3 2023.